Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1

Status

Completed 2Withdrawn 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 78Genitourinary 30Thoracic 11Dermatologic 9CNS 8Sarcoma 5Other hematologic neoplasm 3Tumor-Agnostic 2Other solid neoplasm 2Gynecologic 2Breast 2Other neoplasm 1

Conditions

Leukemia 3Lymphoma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1

Interventions

Cytarabine 898Cyclophosphamide 893fludarabine 517venetoclax 475fludarabine phosphate 464Azacitidine 451Rituximab 418Methotrexate 414Etoposide 319Filgrastim 299Busulfan 295Dexamethasone 284Vincristine 280Daunorubicin 279Peripheral Blood Stem Cell Transplantation 257Whole-Body Irradiation 240Mycophenolic Acid 231Decitabine 228Granulocyte Colony-Stimulating Factor 225Tacrolimus 219Idarubicin 203Melphalan 201Imatinib Mesylate 195Cyclosporine 182Doxorubicin 176Radiotherapy 169Prednisone 161Mitoxantrone 160Lenalidomide 159Mercaptopurine 154

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Vinblastine × Other hematologic neoplasm × Clear all
NCT00488605 2023-08-03

H-9926-LCH III: Treatment Protocol of the Third International Study for Langerhans Cell Histiocytosis

University of New Mexico

Phase 3 Withdrawn
Other hematologic neoplasm

Leukemia

NCT01700946 2022-09-28

Therapy for Pediatric Relapsed or Refractory Precursor B-Cell Acute Lymphoblastic Leukemia and Lymphoma

St. Jude Children's Research Hospital

Phase 2 Completed
80 enrolled 13 charts
LymphoidOther hematologic neoplasm

Leukemia, Lymphoma

NCT00186875 2017-07-28

Therapy for Pediatric Relapsed or Refractory Acute Lymphoblastic Leukemia

St. Jude Children's Research Hospital

Phase 2 Completed
47 enrolled 10 charts
LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡